glp-1 drug market size Size, Share GLP-1 Agonists Weight Loss Drugs
Description
Rooks D, Swan T, Goswami B, Filosa LA, Bunte O, Panchaud N, et al
This was not a new idea
However, the FDA has approved a similar semaglutide (GLP-1 RA) injection for weight loss: Wegovy
Semaglutide has a cumulative exposure of over 22 million patient-years." "We will continue to invest in a variety of disease states including diabetes, chronic kidney disease, obesity, CV disease, liver disease, and Alzheimers disease, as seen in our robust clinical development programs and outcome studies," the statement continued
FAQ What makes retatrutide different from semaglutide
Who wouldnt want some of that
